New modalities, such as cell and gene therapy and mRNA vaccine technology, have increased from 11 to 21 percent of the drug development pipeline—the fastest growth ever seen in the sector. This change is likely to bring more fragmentation of technology, new supply chains, and unique product life cycles.
mRNA isn’t just for COVID anymore! The field is expanding into areas like cancer vaccines, rare genetic disorders, and personalized medicine, making it an exciting space for future pharmacy careers. Its adaptability, rapid development cycles, and growing demand (in R&D, regulatory roles, manufacturing) mean mRNA skills can be a game-changer.
Being a graduate of MSc Biotechnology, I learned the fundamentals of mRNA technology, primarily in gene expression and vaccines, though having only a little exposure to advanced applications, and now firmly at the forefront of innovation in cancer, rare diseases and of course personalized medicine, it is all exciting. I would like to look at opportunities in R&D or regulatory affairs, because mRNA has both scientific novelty and practical effect.
great to know this.
1 Like